2017 annual financial data
Stoke Therapeutics, Inc. 2017 Operating margin
Stoke Therapeutics, Inc. 2017 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -5,554,000 USD and net income was -5,558,000 USD.
Operating cash flow was -5,384,000 USD.
Get free Stoke Therapeutics, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -5,554,000 USD
- Net income
- -5,558,000 USD
- Operating cash flow
- -5,384,000 USD